ACCREDITATION AND CREDIT DESIGNATION
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
Recall current applications of CAR T-cell therapy in hematologic malignancies;
Identify relevant targets and new therapeutic approaches for cellular therapy in solid tumor malignancies;
Define the concept of epitope editing and how it may facilitate the broader application of cellular therapy treatments;
State current advances in cellular therapy engineering including in vivo transduction and through the use of nanoparticles;
Describe current approaches and challenges using cellular therapy in patients with solid tumor malignancies;
List some of the mechanisms of relapse and resistance to cellular therapy;
Discuss current strategies using cellular therapy for the treatment of viral infections and associated conditions;
Evaluate strategies to overcome resistance to cellular therapy treatment approaches;
Assess the clinical applicability of new therapeutic strategies in cellular therapy research.
TECHNICAL SUPPORT
If You Need Technical Support Please Email:
JonasTech@meetingachievements.com
Technical Support Hours:
Friday, September 20, 2024
8:00am – 5:00pm CT